MKS Instruments Investing Cash Flow increased by 49.0% to -$25.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 38.9%, from -$18.00M to -$25.00M. Over 3 years (FY 2022 to FY 2025), Investing Cash Flow shows an upward trend with a -68.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$91.00M | -$251.00M | $23.00M | -$24.00M | -$4.50B | -$52.00M | -$17.00M | -$17.00M | -$16.00M | -$34.00M | -$18.00M | -$26.00M | -$22.00M | -$51.00M | -$18.00M | -$27.00M | -$51.00M | -$49.00M | -$25.00M |
| QoQ Change | — | -175.8% | +109.2% | -204.3% | <-999% | +98.8% | +67.3% | +0.0% | +5.9% | -112.5% | +47.1% | -44.4% | +15.4% | -131.8% | +64.7% | -50.0% | -88.9% | +3.9% | +49.0% |
| YoY Change | — | — | — | +73.6% | <-999% | — | -173.9% | +29.2% | +99.6% | +34.6% | -5.9% | -52.9% | -37.5% | -50.0% | +0.0% | -3.8% | -131.8% | +3.9% | -38.9% |